Smilla SRL
Smilla reported total assets of 70,168 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Smilla shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Smilla's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
Smilla's financial analysis
- Solvency79.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Smilla
Smilla's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1000.480.170
- VAT number
- BE1000480170
- Peppol
- Registered · 0208:1000480170 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Sep 2023
- Registered office
- 3870 Heers
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Smilla (SRL) has been based in Heers since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 22,382 € and equity of 55,858 €; its revenue is not published. Its solvency stands at 79.6%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Smilla
Companies in the same business, of comparable size and area, outside its group.
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
- ES Pharma Retail sale of pharmaceutical products Mol · balance sheet 84,690 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Bossiroy Pharma Retail sale of pharmaceutical products Uccle · balance sheet 65,695 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
- FarmaST Retail sale of pharmaceutical products Zonhoven · balance sheet 107,177 €
- Bartholomees Evaline Retail sale of pharmaceutical products Pelt · balance sheet 120,179 €
Frequently asked questions about Smilla
What is the revenue of Smilla?
Smilla files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Smilla?
In Belgium, the VAT number is the company number prefixed with BE: BE1000480170 for Smilla, if the company is VAT-registered. Its company number (CBE) is 1000.480.170.
Where is the registered office of Smilla?
According to the CBE register, the registered office of Smilla is in 3870 Heers.
What is the equity of Smilla?
At the close of the 2025 financial year, the equity of Smilla amounts to 55,858 €, a solvency of 79.6% of total assets.
Who manages Smilla?
The register lists 1 active mandates at Smilla. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Smilla
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →